Lymphocele disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

MCID: LYM005 MIFTS: 31	Lymphocele Categories: Immune diseases
Genes Tissues Related diseases Publications Drugs Expand all tables

Sources

Aliases & Classifications for Lymphocele

MalaCards integrated aliases for Lymphocele:

Name: Lymphocele ¹² ⁴⁴ ¹⁵ ⁷¹

Lymphocele Adverse Event ⁷¹

Lymph Cyst ¹²

Classifications:

MalaCards categories:
Anatomical: Immune diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:4347

MeSH ⁴⁴ D008210

NCIt ⁵⁰ C78442

SNOMED-CT ⁶⁷ 234109007

UMLS ⁷¹ C0024248 C1963162

Sources

Summaries for Lymphocele

MalaCards based summary : Lymphocele, also known as lymphocele adverse event, is related to urinary tract obstruction and acute cystitis. An important gene associated with Lymphocele is KLK3 (Kallikrein Related Peptidase 3). The drugs Heparin and Hemostatics have been mentioned in the context of this disorder. Affiliated tissues include kidney, lymph node and prostate.

Wikipedia : ⁷⁴ A lymphocele is a collection of lymphatic fluid within the body not bordered by epithelial lining. It is... more...

Sources

Related Diseases for Lymphocele

Diseases related to Lymphocele via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 132)

#	Related Disease	Score	Top Affiliating Genes
1	urinary tract obstruction	29.9	KLK3 ALB
2	acute cystitis	29.7	KLK3 ALB
3	campomelia, cumming type	11.4
4	hydronephrosis	10.3
5	endometrial cancer	10.2
6	pyuria	10.2	KLK3 ALB
7	prostatic hyperplasia, benign	10.2	KLK3 FOLH1
8	hemorrhoid	10.2	KLK3 ALB
9	prostate neuroendocrine neoplasm	10.2	KLK3 FOLH1
10	urethral stricture	10.2	KLK3 FOLH1
11	bladder lateral wall cancer	10.2	KLK3 FOLH1
12	pelvic varices	10.2	KLK3 ALB
13	end stage renal disease	10.2
14	vaginal discharge	10.1	PTPRN ALB
15	villous adenoma	10.1	KLK3 FOLH1
16	placental choriocarcinoma	10.1	MTOR ALB
17	diabetes mellitus, ketosis-prone	10.1	PTPRN ALB
18	sexual disorder	10.1	KLK3 ALB
19	ureteral obstruction	10.1
20	ileus	10.1
21	rectal disease	10.1	KLK3 ALB
22	lymph node carcinoma	10.1	KLK3 FOLH1
23	neurogenic bladder	10.1	KLK3 ALB
24	endodermal sinus tumor	10.1	KLK3 ALB
25	epidural abscess	10.1	POU3F1 ALB
26	hemometra	10.1	PTPRN INSM1
27	isthmus cancer	10.1	PTPRN INSM1
28	ascites, chylous	10.1
29	microinvasive cervical squamous cell carcinoma	10.1	PTPRN INSM1
30	spinal cord disease	10.1	MTOR ALB
31	bleeding disorder, platelet-type, 17	10.1	PTPRN INSM1
32	cervical incompetence	10.1	PTPRN INSM1
33	fallopian tube endometrioid adenocarcinoma	10.0	PTPRN INSM1
34	benign struma ovarii	10.0	PTPRN INSM1
35	exanthem	10.0	MTOR ALB
36	uterus carcinoma in situ	10.0	PTPRN INSM1
37	cervix uteri carcinoma in situ	10.0	PTPRN INSM1
38	ovarian cancer	10.0
39	suppressor of tumorigenicity 3	10.0
40	lymphoproliferative syndrome	10.0
41	polycystic kidney disease	10.0
42	sarcoma	10.0
43	acute kidney tubular necrosis	10.0
44	aortic aneurysm	10.0
45	spindle cell sarcoma	10.0
46	intestinal obstruction	10.0	MTOR ALB
47	hyperphosphatemia	10.0	MTOR ALB
48	aortic aneurysm, familial abdominal, 1	9.9
49	lipomatosis, multiple	9.9
50	prostate cancer	9.9

Graphical network of the top 20 diseases related to Lymphocele:

Sources

Symptoms & Phenotypes for Lymphocele

Sources

Drugs & Therapeutics for Lymphocele

Drugs for Lymphocele (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 19)

Name

Status

Phase

Clinical Trials

Cas Number

PubChem Id

Heparin

Approved, Investigational

Phase 4

9005-49-6

772 9812414

Synonyms:

101921-26-0

102785-31-9

102-94-3

104521-37-1

11078-24-3

11129-39-8

12656-11-0

37324-73-5

9041-08-1

9045-22-1

9075-96-1

913079-23-9

91449-79-5

AC1L1ROY

ALFA 87-120

ALFA 87-163

ALFA 87-198

ALFA 87-81

ALFA 88-247

Allocinnamic acid

alpha-Heparin

Alpha-Heparin

Ardeparin

Ardeparin sodium

Ariven

Arteven

Bemiparin

Bemiparin sodium

Calcilean

Calciparine

Certoparin

CID8784

cis-.beta.-Carboxystyrene

cis-Cinnamic acid

Clexane

Clivarin

Clivarine

CY 216

Cy 222

Dalteparin

Dalteparin sodium

Depo-Heparin

EINECS 232-681-7

Enoxaparin

Enoxaparin sodium

Eparina

Eparina [DCIT]

Fluxum

FR 860

Fragmin A

Fragmin B

Fragmin IV

Fraxiparin

H 2149

Hed-heparin

Hed-Heparin

Hep Flush Kit in plastic container

Hepalean

heparin

Heparin Cy 216

Heparin CY 216

Heparin Leo

Heparin Lock Flush

Heparin Lock Flush in plastic container

Heparin Lock Flush preservative free

Heparin Lock Flush preservative free in plastic container

Heparin natrium

Heparin sodium

Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container

Heparin sodium 1,000 units in dextrose 5% in plastic container

Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container

Heparin sodium 10,000 units in dextrose 5%

Heparin sodium 10,000 units in dextrose 5% in plastic container

Heparin sodium 10,000 units in sodium chloride 0.45%

Heparin sodium 10,000 units in sodium chloride 0.9%

Heparin sodium 12,500 units in dextrose 5%

Heparin sodium 12,500 units in dextrose 5% in plastic container

Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container

Heparin sodium 12,500 units in sodium chloride 0.9%

Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container

Heparin sodium 2,000 units in dextrose 5% in plastic container

Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container

Heparin sodium 20,000 units and dextrose 5% in plastic container

Heparin sodium 20,000 units in dextrose 5% in plastic container

Heparin sodium 25,000 units and dextrose 5% in plastic container

Heparin sodium 25,000 units in dextrose 5%

Heparin sodium 25,000 units in dextrose 5% in plastic container

Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container

Heparin sodium 25,000 units in sodium chloride 0.9%

Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container

Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container

Heparin sodium 5,000 units in dextrose 5% in plastic container

Heparin sodium 5,000 units in sodium chloride 0.45%

Heparin sodium 5,000 units in sodium chloride 0.9%

Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container

Heparin sodium in plastic container

Heparin sodium preservative Free

Heparin sodium salt

Heparin sulfate

Heparin sulphate

Heparin, sodium salt

Heparina

Heparina [INN-Spanish]

Heparinate

Heparine

Heparine [INN-French]

Heparinic acid

Heparinsodiumsalt

Heparinum

Heparinum [INN-Latin]

Heparinum natricum

Hepathrom

Hepflush-10

Hep-Lock

Hep-Lock U/P

HSDB 3094

Innohep

Inno-Hep

Isocinnamic acid

Kabi 2165

KB 101

Leparan

LHN 1

Lioton 1000

Lipo-hepin

Lipo-Hepin

Liquaemin

Liquaemin Lock Flush

Liquaemin Sodium

Liquaemin sodium preservative free

Liquemin

Logiparin

Low molecular weight heparin sodium

Minolteparin sodium

MolPort-003-760-257

Multiparin

Nadroparin

Nadroparine

Novoheparin

NSC174025

Octaparin

OP 386

OP 622

Pabyrin

Panheprin

Parnaparin

Parnaparin sodium

Parvoparin

Pularin

Reviparin

Reviparin sodium

Ro 11

Sandoparin

Sodium acid heparin

Sodium heparin

Sodium heparinate

Subeparin

Sublingula

Thromboliquine

Tinzaparin

Tinzaparin sodium

Triofiban

Unfractionated heparin

UNII-12M44VTJ7B

UNII-3S182ET3UA

UNII-E47C0NF7LV

UNII-T2410KM04A

UNII-ZZ45AB24CA

Vetren

Vitrum AB

WY 90493RD

Hemostatics

Phase 4

Coagulants

Phase 4

Fibrinolytic Agents

Phase 4

Anticoagulants

Phase 4

calcium heparin

Phase 4

lanreotide

Approved

Phase 3

108736-35-2

Somatostatin

Approved, Investigational

Phase 3

51110-01-1, 38916-34-6

53481605

Synonyms:

(5S,8R,14R,17R,20R,23R,26R,29R,32R,35R)-38-[(2-{[(2R)-2-amino-1-hydroxypropylidene]amino}-1-hydroxyethylidene)amino]-20,35-bis(4-aminobutyl)-14,26,29-tribenzyl-7,10,13,16,19,22,25,28,31,34,37-undecahydroxy-32-[(C-hydroxycarbonimidoyl)methyl]-11-(1-hydroxyethyl)-17-[(1S)-1-hydroxyethyl]-8-(hydroxymethyl)-23-[(1H-indol-3-yl)methyl]-1,2-dithia-6,9,12,15,18,21,24,27,30,33,36-undecaazacyclononatriaconta-6,9,12,15,18,21,24,27,30,33,36-undecaene-5-carboxylate

Growth hormone-inhibiting hormone (ghih)

Somatostatin

Somatostatina

Somatostatine

Somatostatinum

Somatotropin release-inhibiting factor (srif)

Somatotropin release-inhibiting hormone

Synthetic growth hormone release-inhibiting hormone

Synthetic somatostatin-14

Cisplatin

Approved

Phase 3

15663-27-1

84093 441203 2767

Synonyms:

(SP-4-1)-diamminedichloridoplatinum

(SP-4-1)-diamminedichloroplatinum

(SP-4-2)-diamminedichloridoplatinum

(SP-4-2)-diamminedichloroplatinum

Abiplatin

Biocisplatinum

Briplatin

CACP

Carboquone

CDDP

CHEBI:35852

CID441203

Cis Pt II

cis-[PtCl2(NH3)2]

cis-DDP

Cis-DDP

Cis-Diaminedichloroplatinum

cis-diamminedichloridoplatinum(II)

cis-Diamminedichloroplatinum

Cis-Diamminedichloroplatinum

cis-diamminedichloroplatinum(II)

cis-Dichlorodiammineplatinum(II)

Cismaplat

Cisplatin

Cisplatine

cisplatino

Cisplatino

Cisplatinum

Cisplatyl

Citoplationo

CPD0-1392

CPDC

CPDD

DB00515

DDP

DDPT

Diamminedichloroplatinum

EU-0100918

Lederplatin

nchembio773-comp1

Neoplatin

Peyrone's chloride

Peyrone's salt

Plastin

Platamine

Platiblastin

Platidiam

Platinex

Platinol

Platinol-AQ

Platinoxan

Platinum Ammine Chloride

Platinum Ammonium Chloride

Platinum Diamine Dichloride

Randa

trans-DDP

Trans-DDP

Trans-Diaminedichloroplatinum

trans-diamminedichloridoplatinum(II)

Trans-Diamminedichloroplatinum

Trans-Dichlorodiammine Platinum

Trans-Platinumdiammine Dichloride

Hormones

Phase 3

Hormone Antagonists

Phase 3

Angiopeptin

Phase 3

Fibrin Tissue Adhesive

Phase 3

Pasireotide

Approved

Phase 2

396091-73-9

9941444

Thrombin

Approved, Investigational

Octreotide

Approved, Investigational

83150-76-9

383414 6400441

Synonyms:

(4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide

(4R,7S,10S,13R,16S,19R)-19-{[(2R)-2-amino-1-hydroxy-3-phenylpropylidene]amino}-10-(4-aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-6,9,12,15,18-pentahydroxy-7-(1-hydroxyethyl)-13-[(1H-indol-3-yl)methyl]-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaene-4-carboximidate

10-(4-Aminobutyl)-19-((2-amino-3-phenylpropanoyl)amino)-16-benzyl-7-(1-hydroxyethyl)-N-(2-hydroxy-1-(hydroxymethyl)propyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaa

10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide

10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide

79517-01-4 (acetate salt)

83150-76-9

AC1L1GVU

AC1L8LCD

AC1L9M4X

C07306

C5H12O2.C4H10

CHEBI:427278

CHEBI:611465

CHEMBL1680

CID383414

CID448601

CID54374

Compound 201 995

Compound 201995

Compound 201-995

D00442

D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-cysteinyl-L-threoninol cyclic (2-7)-disulfide

D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2->7)-disulfide

D-Phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-((1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl)-L-cysteinamide cyclic (2-7)-disulfide

DRG-0115

HMS2090C09

HS-2020

L000453

L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L- threonyl-N-(2-hydroxy-1-(hydroxymethyl)propyl)-, cyclic (2->7)-disulfide, (R-(R*

Longastatin

LS-177735

LS-187135

NCGC00181796-01

nchembio.184-comp3

NCI60_025753

Octreotida

Octreotida [Spanish]

Octreotide

Octreotide (USAN/INN)

Octreotide [USAN:INN:BAN]

Octreotide acetate

Octreotide acetate salt

Octreotide Acetate Salt

Octreotide-LAR

Octreotidum

Octreotidum [Latin]

Octrotide

SAN 201-995

Sandostatin

Sandostatine

Sandoz 201 995

Sandoz 201995

Sandoz 201-995

SM 201-995

SMS 201-995

SMS-201-995

UNII-RWM8CCW8GP

zacycloicosane-4-carboxamide acetate

Pharmaceutical Solutions

Antineoplastic Agents, Hormonal

Gastrointestinal Agents

Interventional clinical trials:

(show all 23)

#	Name	Status	NCT ID	Phase	Drugs
1	Does Intraoperative Application of TachoSil Reduce the Number of Lymphocele After Pelvic Lymphadenectomy?	Completed	NCT03752606	Phase 4
2	Effect of TachoSil® on Incidence of Symptomatic and Radiographic Lymphoceles After Extended Pelvic Lymph Node Dissection in Prostate and Bladder Cancer.	Completed	NCT02001857	Phase 4	1 TachoSil hemostatic sponge (9,5 cm x 4,8 cm) placed on each side on the external iliac artery.
3	A Randomized Controlled Trial for PREvention of VENous ThromboEmbolism Following Radical Prostatectomy (PREVENTER Trial)	Terminated	NCT03006562	Phase 4	Subcutaneous Heparin
4	Prevention of Pelvic Lymphocele by Floseal During Pelvic Lymphadenectomy for Gynecologic Cancer: a Pilot Study	Unknown status	NCT01974193	Phase 3	Floseal
5	A Collagen-Fibrin Patch (Tachosil®) for the Prevention of Symptomatic Lymphoceles After Pelvic Lymphadenectomy in Women With Gynecologic Malignancies: a Randomized Clinical Trial	Completed	NCT01470677	Phase 3	Tachosil fibrin patch
6	Evaluation of the Efficacity of Lanreotide LP 90 mg to Minimized the Lymphorrhea Post Axillary Lymphadenectomy in Breast Cancer	Completed	NCT00630695	Phase 3	Lanreotide LP 90;Placebo lanreotide
7	Efficacy of a Fibrin Sealant (Tissucol Duo®) for the Prevention of Lymphocele After Laparoscopic Pelvic Lymphadenectomy Due to Gynaecological Cancer: a Randomised Controlled Trial	Completed	NCT03914963	Phase 3
8	Application of the Biological Fibrin Based Adhesive for the Prevention of Surgical Complications in the Kidney Transplant	Completed	NCT01631448	Phase 3
9	Observation Versus Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer: A Phase 3 Prospective Multi-institutional Randomised Controlled Trial	Recruiting	NCT03071289	Phase 3	Cisplatin
10	Evaluation of the Effect of Pasireotide LAR Administration in the Lymphocele Prevention After Axillary Node Dissection for Breast Cancer	Completed	NCT01356862	Phase 2	PASIREOTIDE;PLACEBO
11	PREvention of Post-mastectomy LYMphoceles by PAdding. A Randomized Prospective Multicenter Study	Unknown status	NCT02894021
12	Application of Cold Plasma Energy for Reduction of Lymphoceles Following Pelvic Lymph Node Dissection During Robot-Assisted Radical Prostatectomy	Completed	NCT02658851
13	Impact of Peritoneal Closure and Retroperitoneal Drainage on Patients Who Underwent Laparotomic Retroperitoneal Lymph Node Dissection for Early Gynecological Cancer	Completed	NCT03765320
14	Prospective Open Randomized Study to Evaluate the Efficiency of Prophylactic Fenestration of the Peritoneum in Kidney Transplantation in Preventing the Occurrence of Postoperative Lymphoceles	Completed	NCT01206868
15	Application of Thrombin Gel Matrix for the Prevention of Lymphocele in Patients With Endometrial Cancer.	Completed	NCT04205864		Thrombi-Gel
16	THE ROLE OF FLOSEAL IN THE PREVENTION OF LYMPHOCELE AND LYMPHATIC ASCITES AFTER LYMPH NODE DISSECTION FOR GYNECOLOGIC CANCER: A RANDOMIZED CONTROLLED TRIAL	Completed	NCT01679483		FloSeal application
17	A Randomized Control Trial for Lymphocele and Lymphorrhea Control Following Inguinal and Axillary Radical Lymph Node Dissection	Completed	NCT02476357
18	A Pilot Clinical Trial for the Prevention of Lymphoceles After Robotic Pelvic Lymph Node Dissections for Prostate Malignancies Using the da Vinci® EndoWrist® One™ Vessel Sealer	Completed	NCT02035475
19	A Randomized Study Evaluating the Efficacy of the Synthetic Adhesive Solution Ifabond, in Reducing Seroma Formation Post Surgery in Breast Cancer Patients, When Used in Partial Mastectomy With or Without Axillary Lymph Node Dissection	Completed	NCT01742975
20	Management of Symptomatic Post-operative Lymphocele With an Patient-controlled, Vascular Catheter: A Validation Study	Recruiting	NCT02800980
21	The Effect of a Peritoneal Iliac Flap on Lymphocele Formation After Robotic Radical Prostatectomy	Recruiting	NCT03567525
22	Evaluation of Impact of Sandostatin® Injection Before Axillary Clearance on Lymphocele Formation In Patients With Breast Cancer	Terminated	NCT03791736
23	A Pilot Clinical Trial for the Prevention of Postoperative Lymphoceles Using Absorbable Micorporous Polysaccharide Hemosphere Particles During Robotic Assisted Prostatectomy With Lymph Node Dissection	Terminated	NCT01644136

Search NIH Clinical Center for Lymphocele

Cochrane evidence based reviews: lymphocele

Sources

Genetic Tests for Lymphocele

Sources

Anatomical Context for Lymphocele

MalaCards organs/tissues related to Lymphocele:

⁴⁰

Kidney, Lymph Node, Prostate, Skin, Pancreas, Cervix, Heart

Sources

Publications for Lymphocele

Articles related to Lymphocele:

(show top 50) (show all 1212)

#	Title	Authors	PMID	Year
1	Chylopericardium Due to Residual Lymphangiomyoma Detected on 99mTc-Sulfur Colloid Lymphoscintigraphy. ⁶¹	Hemrom A...Kumar R	33323742	2021
2	Fistula formation between infected pelvic lymphocele and sigmoid colon: A rare complication of pelvic lymphadenectomy. ⁶¹	Allioui S...Omor Y	33488904	2021
3	Microbiological analysis of infectious lymphocele: Case series and literature review. ⁶¹	Yamamoto S...Moriya K	32900660	2021
4	Reversed Approach through Lymphocele/Lymphatic Fluid Collection for Glue Embolization of Injured Lymphatic Vessels. ⁶¹	Hur J...Yoon J	33257108	2021
5	Sentinel lymph node biopsy in acral melanoma: A Korean single-center experience with 107 patients (2006-2018). ⁶¹	Sohng C...Lee SJ	33079454	2021
6	Combined double superficial circumflex iliac artery perforator flap with lymphatic tissue preservation and lymphovenous anastomosis for lymphatic sequelae prevention in thigh defect reconstruction: A case report. ⁶¹	Scaglioni MF...Fuchs B	33580739	2021
7	Living versus deceased kidney transplantation: Comparison of complications. ⁶¹	Fakhr Yasseri AM...Dialameh H	33602045	2021
8	Risk Factors, Diagnosis, and Treatment of Lymphocele After Renal Transplantation: A Retrospective Study. ⁶¹	Sevmis M...Sevmis S	33573817	2021
9	Complications of Ileal Conduits after Radical Cystectomy: Interventional Radiologic Management. ⁶¹	Kobayashi K...Jawed M	33306453	2021
10	Combined pedicled superficial circumflex iliac artery perforator (SCIP) flap with lymphatic tissue preservation and lymphovenous anastomosis (LVA) for defect reconstruction and lymphedema-lymphocele prevention in thigh sarcoma surgery: Preliminary results. ⁶¹	Scaglioni MF...Fuchs B	32964444	2021
11	Total groin defect reconstruction by lymphatic flow-through (LyFT) pedicled deep inferior epigastric artery perforator (DIEP) flap resorting to its superficial veins for lymphovenous anastomosis (LVA): A case report. ⁶¹	Scaglioni MF...Fuchs B	33484183	2021
12	RE: Retzius Sparing Prostatectomy Effect on Symptomatic Lymphocele Rates. ⁶¹	Montorsi F...Stabile A	33497719	2021
13	Inguinal seroma/lymphocele prevention after superficial circumflex iliac artery perforator (SCIP) flap harvest using the deep branch as donor vein for lymphovenous anastomosis (LVA). ⁶¹	Scaglioni MF...Fritsche E	32797681	2021
14	Lymphovenous anastomosis (LVA) for treatment of iatrogenic lymphocele in the thigh. ⁶¹	Scaglioni MF...Fritsche E	32343453	2021
15	Lymphatic embolization for the management of symptomatic pelvic lymphocele after radical prostatectomy with lymph node dissection: Report of two cases. ⁶¹	Schneider G...Colombel M	33426486	2021
16	A risk factor analysis of complications after surgery for vulvar cancer. ⁶¹	Gitas G...Alkatout I	33420814	2021
17	Lymphatic Leaks of the Thigh and Inguinal Region: Combined Plastic Surgery Approaches for an Effective Treatment Algorithm. ⁶¹	Watfa W...di Summa PG	32118638	2020
18	Retzius Sparing Prostatectomy Effect on Symptomatic Lymphocele Rates. ⁶¹	Wong D...Kim E	33279613	2020
19	Anatomical characterization of the inguinal lymph nodes using microcomputed tomography to inform radical inguinal lymph node dissections in penile cancer. ⁶¹	Marshall K...Power NE	32914446	2020
20	Internal hernia beneath superior vesical artery after pelvic lymphadenectomy for cervical cancer: a case report and literature review. ⁶¹	Ai W...Yu H	33267803	2020
21	Hybrid procedures in the dialysis fistula aneurysm treatment. ⁶¹	Gora R...Andziak P	32522136	2020
22	Povidone-iodine sclerotherapy of primary symptomatic lymphocele after kidney transplantation. ⁶¹	Baboudjian M...Boissier R	33170487	2020
23	Application of thrombin gel matrix for the prevention of lymphocele in patients with endometrial cancer: A prospective randomized trial. ⁶¹	Gezer S...Yucesoy I	33217600	2020
24	Conventional Lymphangiography (CL) in the Management of Postoperative Lymphatic Leakage (PLL): A Systematic Review. ⁶¹	Sommer CM...Richter GM	32215900	2020
25	Imaging features, complications and differential diagnoses of abdominal cystic lymphangiomas. ⁶¹	Raufaste Tistet M...Lebert P	32296900	2020
26	Managing Patients with Prostate Cancer During COVID-19 Pandemic: The Experience of a High-Volume Robotic Surgery Center. ⁶¹	Moschovas MC...Patel V	32940059	2020
27	Diagnostic clues, pitfalls, and imaging characteristics of '-celes' that arise in abdominal and pelvic structures. ⁶¹	Srisajjakul S...Bangchokdee S	32356005	2020
28	Rare case of giant lymphocele treated with supramicrosurgical approach. ⁶¹	Gabriele G...Gennaro P	33337431	2020
29	Distribution of lymphocele following lymphadenectomy in patients with gynecological malignancies. ⁶¹	Song SY...Yoo HJ	32814372	2020
30	Lymphocele Containing Staphylococcus lugdunensis. ⁶¹	Keerty D...Haynes E	33391904	2020
31	Cervical lymphocele: A rare complication following salvage surgery for ocular adnexal apocrine adenocarcinoma. A case report and review of the literature. ⁶¹	Hauer L...Merglova V	33252115	2020
32	Negative Pressure Wound Therapy (NPWT) in Groin Wounds After Lymphadenectomy in Vulvar Cancer Patients. ⁶¹	Asciutto KC...Borgfeldt C	33144461	2020
33	Percutaneous afferent lymphatic vessel sclerotherapy for postoperative lymphatic leakage after previous ineffective therapeutic transpedal lymphangiography. ⁶¹	Pan F...Sommer CM	33135104	2020
34	Robot-assisted nipple-sparing mastectomy: systematic review. ⁶¹	Angarita FA...Cil TD	32846014	2020
35	The effect of peritoneal re-approximation on lymphocele formation in transperitoneal robot-assisted radical prostatectomy and extended pelvic lymphadenectomy. ⁶¹	Boga MS...Ates M	32833618	2020
36	A meta-analysis evaluating the intra-operative use of collagen-fibrin sealants during inguino-femoral lymphadenectomy: A new direction in reducing post-operative morbidity or another disappointment? ⁶¹	Tranoulis A...Montalto SA	32788096	2020
37	Lipofilled Mini Dorsi Flap: An Efficient Less Invasive Concept for Immediate Breast Reconstruction. ⁶¹	Piat JM...Ho Quoc C	32032119	2020
38	Surgical learning curve in kidney transplantation: A systematic review and meta-analysis. ⁶¹	Outmani L...Minnee RC	32624245	2020
39	Wound healing adverse events in kidney transplant recipients receiving everolimus with reduced calcineurin inhibitor exposure or current standard-of-care: insights from the 24-month TRANSFORM study. ⁶¹	Citterio F...Watarai Y	32633157	2020
40	Long-term Follow-up of ABO-Incompatible Kidney Transplantation in Freiburg, Germany: A Single-Center Outcome Report. ⁶¹	Langhorst C...Zschiedrich S	33041078	2020
41	Lomboaortic Lymphadenectomy in Gynecological Oncology: Laparotomy, Laparoscopy or Robot-Assisted Laparoscopy? ⁶¹	Kerbage Y...Narducci F	32472415	2020
42	PREventive effect of FENestration with and without clipping on post-kidney transplantation lymphatic complications (PREFEN): study protocol for a randomised controlled trial. ⁶¹	Golriz M...Mehrabi A	33051226	2020
43	Sclerotherapy With OK-432 for the Treatment of Symptomatic Lymphocele After Lymph Node Dissection: A Retrospective Comparative Cohort Study. ⁶¹	Uyulmaz S...Lindenblatt N	32000251	2020
44	Early Postoperative Complications and Outcomes of Kidney Transplantation in Moderately Obese Patients. ⁶¹	Warzyszynska K...Kosieradzki M	32252995	2020
45	Robotic-assisted kidney transplant: a single center experience with median follow-up of 2.8 years. ⁶¹	Ganpule A...Desai M	31489478	2020
46	Impact of Sentinel Node Mapping in Decreasing the Risk of Lymphocele in Endometrial Cancer. ⁶¹	Diniz TP...Baiocchi G	33108597	2020
47	Effect of Pharmacologic Prophylaxis on Venous Thromboembolism After Radical Prostatectomy: The PREVENTER Randomized Clinical Trial. ⁶¹	Patel HD...Allaf ME	32444264	2020
48	Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion. ⁶¹	Oderda M...Gontero P	32869940	2020
49	Major complications of post-chemotherapy retroperitoneal lymph node dissection in a contemporary cohort of patients with testicular cancer and a review of the literature. ⁶¹	Ruf CG...Dieckmann KP	32972425	2020
50	Treatment Outcomes in Patients With Symptomatic Lymphoceles Following Radical Prostatectomy Depend Upon Size and Presence of Infection. ⁶¹	Andrews JR...Tollefson MK	32562773	2020

Sources

Genes for Lymphocele

Genes related to Lymphocele (0 elite genes):

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence
1	KLK3	Kallikrein Related Peptidase 3	Protein Coding	7.1	DISEASES inferred ¹⁵
2	MTOR	Mechanistic Target Of Rapamycin Kinase	Protein Coding	6.44	DISEASES inferred ¹⁵
3	PTPRN	Protein Tyrosine Phosphatase Receptor Type N	Protein Coding	6.13	DISEASES inferred ¹⁵
4	CAGE1	Cancer Antigen 1	Protein Coding	5.81	DISEASES inferred ¹⁵
5	ALB	Albumin	Protein Coding	5.71	DISEASES inferred ¹⁵
6	FOLH1	Folate Hydrolase 1	Protein Coding	5.58	DISEASES inferred ¹⁵
7	POU3F1	POU Class 3 Homeobox 1	Protein Coding	5.46	DISEASES inferred ¹⁵
8	INSM1	INSM Transcriptional Repressor 1	Protein Coding	5.45	DISEASES inferred ¹⁵
9	VEGFC	Vascular Endothelial Growth Factor C	Protein Coding	5.28	DISEASES inferred ¹⁵
10	LYVE1	Lymphatic Vessel Endothelial Hyaluronan Receptor 1	Protein Coding	5.07	DISEASES inferred ¹⁵

Sources

Variations for Lymphocele

Sources

Expression for Lymphocele

Search GEO for disease gene expression data for Lymphocele.

Sources

Pathways for Lymphocele

Sources

GO Terms for Lymphocele

Sources

Sources for Lymphocele

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FMA

²⁰ GARD

²¹ GeneAnalytics

²² GeneCards

²³ GeneGo (Thomson Reuters)

²⁴ GeneHancer via GeneCards

²⁵ GeneReviews

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HMDB

³¹ HPO

³² ICD10

³³ ICD10 via Orphanet

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ KEGG

³⁷ LifeMap

³⁸ LncRNADisease

³⁹ LOVD

⁴⁰ MalaCards

⁴¹ MedGen

⁴² MedlinePlus

⁴³ MedlinePlus Genetics

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NINDS

⁵⁴ Novoseek

⁵⁵ Novus Biologicals

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 05-Mar-2021)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubMed

⁶² PubMed Health

⁶³ QIAGEN

⁶⁴ R&D Systems

⁶⁵ Reactome

⁶⁶ Sino Biological

⁶⁷ SNOMED-CT

⁶⁸ SNOMED-CT via HPO

⁶⁹ TGDB

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ Wikipedia